DOD Biotech PCL's ROE % for the quarter that ended in Mar. 2026 was -9.22%. DOD Biotech PCL's PB Ratio for the quarter that ended in Mar. 2026 was 0.83.
DOD Biotech PCL's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -11.11%.
DOD Biotech PCL ROE % Adjusted to Book Value Related Terms
DOD Biotech PCL ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for DOD Biotech PCL's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DOD Biotech PCL ROE % Adjusted to Book Value Chart
BKK:DOD vs KHC, GIS: ROE % Adjusted to Book Value Comparison
For the Packaged Foods subindustry, DOD Biotech PCL's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DOD Biotech PCL ROE % Adjusted to Book Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, DOD Biotech PCL's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where DOD Biotech PCL's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -11.11% mean?
DOD Biotech PCL (BKK:DOD) has a ROE % Adjusted to Book Value of -11.11% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on DOD Biotech PCL and its competitors.
Is DOD Biotech PCL's ROE % Adjusted to Book Value too high?
DOD Biotech PCL's current ROE % Adjusted to Book Value is -11.11%. Overall, DOD Biotech PCL has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DOD Biotech PCL's ROE % Adjusted to Book Value compare to KHC and GIS?
DOD Biotech PCL's ROE % Adjusted to Book Value of -11.11% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Consumer Packaged Goods company?
A good ROE % Adjusted to Book Value depends on the Consumer Packaged Goods industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on DOD Biotech PCL and its competitors. DOD Biotech PCL's current ROE % Adjusted to Book Value is -11.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DOD Biotech PCL stock overvalued right now?
Based on GuruFocus' analysis, DOD Biotech PCL (BKK:DOD) is currently considered Modestly Undervalued. The stock's GF Value™ is ฿1.67, compared to a current price of ฿1.18 — trading 29.3% below its estimated fair value. The current ROE % Adjusted to Book Value is -11.11%. DOD Biotech PCL's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For DOD Biotech PCL (BKK:DOD), the current ROE % Adjusted to Book Value is -11.11% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DOD Biotech PCL (BKK:DOD) Overvalued in 2026?
Based on GuruFocus' analysis, DOD Biotech PCL stock appears to be undervalued.
The current stock price of ฿1.18 is trading 29.3% below its estimated GF Value™ of ฿1.67.
GuruFocus considers DOD Biotech PCL to be Modestly Undervalued.
Key valuation signals for BKK:DOD:
ROE % Adjusted to Book Value: -11.11%
GF Value™: ฿1.67 vs. price of ฿1.18 (29.3% below fair value)
No single metric tells the full story. See the BKK:DOD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The group is principally engaged in the supplement business. Its operations are carried on only in Thailand. Its products include: Capsule; Gel; Jelly; Powder for making drinks; Concentrated water extract (Shot Drink); Softgel; Tablet; Probiotics; Gummies; and Direct-to-Mouth Packaging.
78GF Score
Get the complete analysis for BKK:DOD
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:DOD has been successfully added to your 
